Regentis Biomaterials Ltd. (RGNT)
Regentis Biomaterials will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$10.00 - $12.00
Shares Offered
909,090
Deal Size
$10.00M
Regentis Biomaterials Statistics
Total Valuation
RGNT has a market cap or net worth of $53.22 million. The enterprise value is $55.74 million.
Market Cap | 53.22M |
Enterprise Value | 55.74M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
RGNT has 4.84 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 4.84M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 8.37.
PE Ratio | 8.37 |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 8.76 |
EV / Sales | n/a |
EV / EBITDA | 6.52 |
EV / EBIT | 6.52 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | 0.31 |
Debt / FCF | n/a |
Interest Coverage | 3.92 |
Financial Efficiency
Return on equity (ROE) is -16.44% and return on invested capital (ROIC) is -3.19%.
Return on Equity (ROE) | -16.44% |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | -3.19% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | $2.12M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | 1.15M |
Pretax Income | 6.36M |
Net Income | 6.36M |
EBITDA | 8.54M |
EBIT | 8.54M |
Earnings Per Share (EPS) | $1.31 |
Balance Sheet
The company has $176,000 in cash and $2.69 million in debt, giving a net cash position of -$2.51 million or -$0.52 per share.
Cash & Cash Equivalents | 176,000 |
Total Debt | 2.69M |
Net Cash | -2.51M |
Net Cash Per Share | -$0.52 |
Equity (Book Value) | -38.70M |
Book Value Per Share | -8.00 |
Working Capital | -914,000 |
Cash Flow
Operating Cash Flow | -459,000 |
Capital Expenditures | n/a |
Free Cash Flow | -459,000 |
FCF Per Share | -$0.09 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RGNT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 11.95% |
FCF Yield | -0.86% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |